Methods and compositions for the identification of metastatic human tumors
CA 1307478 C · Owner: Nicolson, Garth L. · Inventors: Steck, Peter A.; Nicolson, Garth L.; North, Susan M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are monoclonal antibodies which react with human tumor cells, particularly metastatic human tumor cells, but not with normal human tissues tested. The monoclonal antibodies are prepared against a 580 kilodalton glycoprotein antigen, designated gp580 which, is isolated from either rat or human tumor cells. Methods for isolating the glycoprotein antigen are disclosed as well. Moveover, techniques are disclosed for utilizing these antibodies both in the detection and in the prevention of human tumor lesions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 15, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 15, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.